Page last updated: 2024-11-06

mitomycin and Systemic Inflammatory Response Syndrome

mitomycin has been researched along with Systemic Inflammatory Response Syndrome in 2 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mbeutcha, A1
Shariat, SF1
Rieken, M1
Rink, M1
Xylinas, E1
Seitz, C1
Lucca, I1
Mathieu, R1
Rouprêt, M1
Briganti, A1
Karakiewicz, PI1
Klatte, T1
Elmer, A1
Bermes, U1
Drath, L1
Büscher, E1
Viertel, A1

Other Studies

2 other studies available for mitomycin and Systemic Inflammatory Response Syndrome

ArticleYear
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
    Urologic oncology, 2016, Volume: 34, Issue:11

    Topics: Adjuvants, Immunologic; Aged; Antineoplastic Agents; BCG Vaccine; Biomarkers; C-Reactive Protein; Ca

2016
[Sepsis and multiple organ failure after BCG-instillation for bladder cancer].
    Der Internist, 2004, Volume: 45, Issue:8

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Bacteriuria; BCG Vaccine; Biopsy; Bone Marrow;

2004